Amanote Research

Amanote Research

    RegisterSign In

Drug Trial Investigators Asked to Declare Financial Interests

BMJ
doi 10.1136/bmj.318.7187.831
Full Text
Open PDF
Abstract

Available in full text

Date

March 27, 1999

Authors
A. Ferriman
Publisher

BMJ


Related search

Nothing to Declare?

Nature Methods
BiochemistryBiotechnologyCell BiologyMolecular Biology
2006English

GPs Asked Not to Demand Payments From Drug Company Representatives

BMJ
2004English

Cash Interests Taint Drug Advice

Nature
Multidisciplinary
2005English

Generic Substitution, Financial Interests, and Imperfect Agency

International Journal of Health Care Finance and Economics
2013English

PHP95 Prescription Monitoring Program Effectiveness: Perceptions of Drug Diversion Investigators

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

DECLARE-TIMI 58 Trial in the Context of EMPA-REG OUTCOME and CANVAS

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

How Do Parents Experience Being Asked to Enter a Child in a Randomised Controlled Trial?

BMC Medical Ethics
Health PolicyEthicsHealthIssuesLegal Aspects
2009English

An Ontology to Semantically Declare and Describe Functions

Lecture Notes in Computer Science
Computer ScienceTheoretical Computer Science
2016English

Landed Interests and Financial Underdevelopment in the United States

SSRN Electronic Journal
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy